Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	179.08	118.75	42.55
Graham Fair Price	-18.88	2.51	3.09
PEG	-79.90	-0.66	3.28
Price/Book	2.15	0.61	0.60
Price/Cash Flow	-63.67	-7.24	19.94
Prices/Earnings	57.42	22.90	14.54
Price/Sales	-22.24	1.73	2.22
Price/FCF	-63.67	-7.24	19.94
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-31.75	0.04	0.06
Operating Margin	-20.36	< 0.005	0.01
ROA	-34.16	< 0.005	< 0.005
ROE	0.01	< 0.005	-35.11
ROIC	< 0.005	< 0.005	31.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.09	-82.37
Dividends QOQ	-0.85	0.71	-16.79
EBIT QOQ	-0.79	0.05	-93.22
EPS QOQ	0.04	-0.35	683.16
FCF QOQ	-0.18	-3.83	-1994.55
Revenue QOQ	-0.42	0.32	-22.96
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.92	72.81	-7.75
Days Sales Outstanding (DSO)	96.11	92.28	-3.98
Inventory Turnover	1.14	1.24	8.40
Debt/Capitalization	0.39	0.39	-1.38
Quick Ratio	0.91	0.96	5.56
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.42	6.47	0.70
Cash	2.64	1.73	-34.70
Capex	-0.07	-0.06	11.17
Free Cash Flow	0.19	-0.55	183.17
Revenue	1.73	2.29	32.29
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.25	1.45	16.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.02	44.44	269.83
Naive Interpretation	Member

06 - Financial Health · Weak

Rating